Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07122960

Strengthening Informed Consent for Authentic Participation in Perinatal HIV Research

This study evaluates a visual Informed Consent Form (ICF) compared to a standard, text-only ICF as an approach to achieving meaningful consent into a clinical trial. The visual ICF uses cartoon characters, graphics and easy-to-understand text to cover the full content of a standard, text-only ICF. In this study, women who are considering enrollment into a clinical trial of a nutrition intervention for their infants will be randomized to either the visual ICF or to the text-only ICF. Qualitative and quantitative data will be collected immediately after the consent process and 8 weeks later. In addition, women not eligible for enrollment into the infant nutrition trial will be asked questions about their opinions regarding the visual ICF. The overall goal of the sub-study is to inform efforts to improve meaningful consent into clinical trials by evaluating whether the visual ICF improves understanding of the trial.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Age range

18 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Stellenbosch University Wooster Rural Campus

Worcester, Western Cape, 6850, South Africa

About this study

The overall goal of the study is to inform efforts to improve meaningful consent into clinical trials. The investigators are evaluating whether substituting a visual informed consent form (ICF) for the usual text-only ICF will increase potential participants' understanding of the risks and benefits of research and contribute to more informed participation.

This study is nested within a larger clinical trial of a nutrition intervention for infants underway in South Africa. For this larger trial, a visual ICF was developed that covers the identical content of a standard text-only ICF. For this sub-study (n=40), women who are considering enrollment into this larger study who agree to enroll in the sub-study, will be randomized to either receive the visual ICF or to receive the text-only ICF. Following the decision to either participate or not in the larger trial, women will be interviewed about their knowledge recall of the content of the ICF including concerning the trial goal, the voluntary nature of participation, potential benefits, potential risks, and randomization measured using a mix of true/false/uncertain and likert-type response options. Questions will also be asked about decision conflict, self-rated understanding, self-efficacy, and satisfaction with the informed consent process. Eight weeks later, at one of the follow-up visits in the larger trial, these questions will be repeated to determine knowledge retention and decision regret and trust in the study team. The evaluation includes both quantitative and qualitative data which will be analyzed using standard mixed methods analysis techniques.

In addition, an independent population of women from the same area with infants of the same age but who are not eligible for the larger trial will be enrolled (n=20). For this population, participating in the trial is a hypothetical situation and thus respondents have no direct connection with the study team and thus are less prone to positive bias in responses. Questions will be asked concerning opinions about the visual ICF using a semi-structured, qualitative, think-aloud approach.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women ages 18-45 years of age
  • Pregnant women or women that have recently given birth within the past 2-6 weeks

Exclusion criteria

  • Unwilling to provide consent
  • Severe maternal or infant illness (e.g. tuberculosis, major psychiatric or neurological conditions)
  • Inability to communicate in one of the three languages (English, isiXhosa, or Afrikaans)

Treatment and study plan

Visual ICF

Other

This visual ICF fully represents all the content of the standard, text-only ICF using cartoon characters, graphics and easy text.

Text-only ICF

Other

Text-only ICF

Primary outcomes

  1. Summed score from the validated Quality of Informed Consent (QUIC) instrument.

    Time frame: Immediately after the consent process (Day 0) and 8 weeks later

    The QUIC measures knowledge recall. The summed score of 10 knowledge items comprising key concepts of informed consent will be calculated. The scores range between 0 and 22 with higher scores indicating higher knowledge.

Secondary outcomes

  1. Self-rated Understanding

    Time frame: Immediately after consent process (Day 0)

    Six item self-rated assessment of understanding, which extends beyond knowledge recall to assess comprehension and ability to assimilate information. Scores range between 0-12 with higher scores indicating better understanding.

  2. Decision Regret Scale

    Time frame: 8 weeks after consent process

    Validated measure with 5 items assessing attitudes about the decision making outcome. The possible score ranges are 0-10 with higher scores indicating less regret.

Sponsors and collaborators

Lead sponsor

Columbia University

Other

Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  • University of Stellenbosch

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2027
First posted
Aug 14, 2025
Registry last updated
Jul 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.